{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:52:18Z","timestamp":1784011938002,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Division of Intramural Research, National Cancer Institute"},{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A Kids' Brain Tumor Cure"},{"name":"McKenna Claire Foundation"},{"DOI":"10.13039\/100003156","name":"Musella Foundation For Brain Tumor Research and Information","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010341","name":"Prayers from Maria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00280-019-04021-y","type":"journal-article","created":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T23:02:27Z","timestamp":1577919747000},"page":"827-830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma"],"prefix":"10.1007","volume":"85","author":[{"given":"Louis T.","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Lester McCully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Odabas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"issue":"3","key":"4021_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","volume":"7","author":"D Hargrave","year":"2006","unstructured":"Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241\u2013248","journal-title":"Lancet Oncol"},{"issue":"6","key":"4021_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/CCO.0b013e32831186e0","volume":"20","author":"F Laigle-Donadey","year":"2008","unstructured":"Laigle-Donadey F, Doz F, Delattre JY (2008) Brainstem gliomas in children and adults. Curr Opin Oncol 20(6):662\u2013667","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"4021_CR3","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.1101657108","volume":"108","author":"M Monje","year":"2011","unstructured":"Monje M, Mitra SS, Freret ME et al (2011) Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci USA 108(11):4453\u20134458","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"4021_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","volume":"110","author":"R Hashizume","year":"2012","unstructured":"Hashizume R, Smirnov I, Liu S et al (2012) Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment. J Neurooncol 110(3):305\u2013313","journal-title":"J Neurooncol"},{"issue":"3","key":"4021_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","volume":"124","author":"DA Khuong-Quang","year":"2012","unstructured":"Khuong-Quang DA, Buczkowicz P, Rakopoulos P et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124(3):439\u2013447","journal-title":"Acta Neuropathol"},{"key":"4021_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251\u2013253","journal-title":"Nat Genet"},{"issue":"7384","key":"4021_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu XY et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231","journal-title":"Nature"},{"key":"4021_CR8","unstructured":"FARYDAK (Panobinostat) [package insert] (2015) Novartis Pharmaceuticals Corporation, East Hanover"},{"issue":"7","key":"4021_CR9","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):555\u2013559","journal-title":"Nat Med"},{"key":"4021_CR10","doi-asserted-by":"publisher","first-page":"320941","DOI":"10.1155\/2015\/320941","volume":"2015","author":"A Bhowmik","year":"2015","unstructured":"Bhowmik A, Khan R, Ghosh MK (2015) Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int 2015:320941","journal-title":"Biomed Res Int"},{"issue":"suppl_2","key":"4021_CR11","doi-asserted-by":"publisher","first-page":"i157","DOI":"10.1093\/neuonc\/noy059.582","volume":"20","author":"E Baratz","year":"2018","unstructured":"Baratz E, McCully C, Shih J et al (2018) Comparison of pharmacokinetic parameters between non-human primates and human patients. Neuro Oncol 20(suppl_2):i157","journal-title":"Neuro Oncol"},{"issue":"1","key":"4021_CR12","first-page":"77","volume":"65","author":"CM Lester McCully","year":"2015","unstructured":"Lester McCully CM, Bacher J, MacAllister RP, Steffen-Smith EA, Saleem K, Thomas ML 3rd, Cruz R, Warren KE (2015) Development of a cerebrospinal fluid lateral reservoir model in rhesus monkeys (Macaca mulatta). Comp Med 65(1):77\u201382","journal-title":"Comp Med"},{"key":"4021_CR13","doi-asserted-by":"crossref","unstructured":"National Research Council (2011) Guide for the care and use of laboratory animals, 8th edn. The National Academies Press, Washington, DC. https:\/\/doi.org\/10.17226\/12910.","DOI":"10.17226\/12910"},{"issue":"6","key":"4021_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00228-015-1846-7","volume":"71","author":"M Savelieva","year":"2015","unstructured":"Savelieva M, Woo MM, Schran H, Mu S, Nedelman J, Capdeville R (2015) Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors. Eur J Clin Pharmacol 71(6):663\u2013672","journal-title":"Eur J Clin Pharmacol"},{"key":"4021_CR15","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1158\/1078-0432.CCR-07-4262","volume":"14","author":"L Ellis","year":"2008","unstructured":"Ellis L, Pan Y, Smyth GK et al (2008) Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma. Clin Cancer Res 14:4500\u20134510","journal-title":"Clin Cancer Res"},{"key":"4021_CR16","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd4360","volume":"13","author":"KJ Falkenberg","year":"2014","unstructured":"Falkenberg KJ, Johnstone RW (2014) Histone deacetylases and their inhibitors in cancer, neurological diseases, and immune disorders. Nat Rev Drug Discov 13:673\u2013691 (published correction appears in Nat Rev Drug Discov 2015; 14:219)","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"4021_CR17","doi-asserted-by":"publisher","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","volume":"12","author":"T Hennika","year":"2017","unstructured":"Hennika T, Hu G, Olaciregui NG et al (2017) Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. PLoS ONE 12(1):e0169485","journal-title":"PLoS ONE"},{"key":"4021_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","volume":"117","author":"Y Uchida","year":"2011","unstructured":"Uchida Y, Ohtsuki S, Katsukura Y et al (2011) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333\u2013345","journal-title":"J Neurochem"},{"issue":"5","key":"4021_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2133\/dmpk.DMPK-14-RG-026","volume":"29","author":"Y Nagaya","year":"2014","unstructured":"Nagaya Y, Nozaki Y, Kobayashi K, Takenaka O, Nakatani Y, Kusano K, Yoshimura T, Kusuhara H (2014) Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates. Drug Metab Pharmacokinet 29(5):419\u2013426","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"4021_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/neuonc\/nox175","volume":"20","author":"JN Sarkaria","year":"2018","unstructured":"Sarkaria JN, Hu LS, Parney IF et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20(2):184\u2013191","journal-title":"Neuro Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-04021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-04021-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-04021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:17:28Z","timestamp":1609373848000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-04021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["4021"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-04021-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"15 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}